| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -5,0 k € | +25.9% | -6,8 k € | -188.5% | -2,4 k € | -100.5% | 436,5 k € | +456.2% | -122,6 k € | +64.0% | -340,3 k € | +17.5% | -412,6 k € | +34.3% | -628,3 k € | -16.7% | -538,2 k € | +21.1% | -682,3 k € | +22.7% | -882,9 k € | -42.8% | -618,3 k € | -38.3% | -447,2 k € | |
| EBITDA | -5,4 k € | +24.8% | -7,2 k € | -163.9% | -2,7 k € | -100.6% | 430,8 k € | +426.3% | -132,0 k € | +62.7% | -353,8 k € | +14.5% | -413,7 k € | +41.1% | -702,1 k € | -2.1% | -687,5 k € | +11.2% | -774,6 k € | +20.9% | -978,7 k € | -32.9% | -736,2 k € | -45.9% | -504,5 k € | |
| Operating profit | -5,4 k € | +24.8% | -7,2 k € | -163.9% | -2,7 k € | -100.6% | 430,8 k € | +419.9% | -134,7 k € | +62.3% | -357,3 k € | +15.2% | -421,3 k € | +41.9% | -724,5 k € | -0.7% | -719,2 k € | +11.3% | -810,7 k € | +20.0% | -1,0 M € | -32.3% | -765,9 k € | -49.8% | -511,2 k € | |
| Profit/loss | -5,3 k € | +27.1% | -7,3 k € | +90.4% | -76,0 k € | -214.0% | 66,6 k € | +166.8% | -99,8 k € | +89.6% | -959,1 k € | +22.7% | -1,2 M € | -22.8% | -1,0 M € | +21.5% | -1,3 M € | +12.8% | -1,5 M € | +43.4% | -2,6 M € | -247.4% | -750,6 k € | -26.1% | -595,0 k € | |
| Equity | -103,4 k € | -5.4% | -98,1 k € | -8.1% | -90,8 k € | -513.8% | -14,8 k € | +87.1% | -115,0 k € | +94.9% | -2,3 M € | -73.4% | -1,3 M € | -1846.3% | -67,2 k € | +93.1% | -967,5 k € | +24.2% | -1,3 M € | -740.8% | 199,1 k € | -88.6% | 1,8 M € | +21.1% | 1,4 M € | |
| Total assets | 267,4 k € | -2.1% | 273,0 k € | -2.8% | 280,8 k € | -21.3% | 356,9 k € | -42.9% | 625,2 k € | +849.6% | 65,8 k € | -75.7% | 270,6 k € | -38.7% | 441,4 k € | +165.4% | 166,3 k € | -37.7% | 267,2 k € | -70.9% | 918,9 k € | -62.5% | 2,5 M € | +18.1% | 2,1 M € | |
| Cash | 43,9 k € | -14.1% | 51,1 k € | -13.3% | 59,0 k € | +2.4% | 57,6 k € | +203.8% | 19,0 k € | -62.0% | 49,9 k € | -72.8% | 183,8 k € | -43.6% | 325,9 k € | +315.2% | 78,5 k € | -19.7% | 97,8 k € | -74.1% | 377,8 k € | -70.9% | 1,3 M € | -14.0% | 1,5 M € | |
| Debts | 368,2 k € | 0.0% | 368,2 k € | -0.1% | 368,7 k € | 0.0% | 368,7 k € | -23.4% | 481,6 k € | -79.3% | 2,3 M € | +51.3% | 1,5 M € | +243.9% | 448,3 k € | -59.0% | 1,1 M € | -25.7% | 1,5 M € | +182.2% | 521,6 k € | +3.9% | 501,9 k € | -16.9% | 604,2 k € | |
| Staff | — | — | — | — | — | — | — | 0,3 | 1 | 1 | 1 | 1 | 0,3 | |||||||||||||
Public limited company · Zaventem · incorporated on 22/07/2013
Public limited company loss-making in the latest fiscal year. Cash position declining (-14.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
TROD MEDICAL is a Public limited company incorporated in 2013. Its registered office is in Zaventem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette